News zum Sektor Gesundheit aus Australien & Ozeanien

Es sind 100 ETFs & Fonds zum Sektor Gesundheit bekannt.

Es sind 1574 Aktien zum Sektor Gesundheit bekannt.

>Gesundheit News Australien & Ozeanien
- Top- News
- Alle News
- Branchenanalysen
- Aktienanalysen
- News zum Land A..
  - Afghanistan
  - Afrika
  - Albanien
  - Algerien
  - Angola
  - Argentinien
  - Armenien
  - Aserbaidschan
  - Asien
  - Australien
  - Australien & Ozeanien
- News zum Land B..
  - Bahamas
  - Bahrain
  - Bangladesch
  - Barbados
  - Belgien
  - Belize
  - Benin
  - Bermuda
  - Bhutan
  - Bolivien
  - Bosnien und Herzegowina
  - Botswana
  - Brasilien
  - Britische Jungferninseln
  - Brunei
  - Bulgarien
  - Burkina Faso
  - Burundi
- News zum Land C..
  - Chile
  - China
  - Costa Rica
- News zum Land D..
  - Deutschland
  - Dominikanische Republik
  - Dschibuti
  - Dänemark
- News zum Land E..
  - Ecuador
  - El Salvador
  - Elfenbeinküste
  - Eritrea
  - Estland
  - Europa
- News zum Land F..
  - Fidschi
  - Finnland
  - Frankreich
- News zum Land G..
  - Gabun
  - Gambia
  - Georgien
  - Ghana
  - Griechenland
  - Großbritannien
  - Grönland
  - Guatemala
  - Guinea
  - Guyana
- News zum Land H..
  - Haiti
  - Honduras
  - Hong Kong (China)
- News zum Land I..
  - Indien
  - Indonesien
  - Irak
  - Iran
  - Irland
  - Island
  - Israel
  - Italien
- News zum Land J..
  - Jamaika
  - Japan
  - Jemen
  - Jordanien
- News zum Land K..
  - Kaimaninseln
  - Kambodscha
  - Kamerun
  - Kanada
  - Kasachstan
  - Katar
  - Kenia
  - Kirgisistan
  - Kolumbien
  - Kongo
  - Kosovo
  - Kroatien
  - Kuba
  - Kuwait
- News zum Land L..
  - Laos
  - Lateinamerika
  - Lesotho
  - Lettland
  - Libanon
  - Liberia
  - Libyen
  - Liechtenstein
  - Litauen
  - Luxemburg
- News zum Land M..
  - Madagaskar
  - Malawi
  - Malaysia
  - Mali
  - Marokko
  - Mauretanien
  - Mauritius
  - Mexiko
  - Moldawien
  - Mongolei
  - Montenegro
  - Mosambik
  - Myanmar
- News zum Land N..
  - Naher Osten
  - Namibia
  - Nepal
  - Neuseeland
  - Nicaragua
  - Niederlande
  - Niger
  - Nigeria
  - Nordamerika
  - Nordkorea
  - Nordmazedonien
  - Norwegen
- News zum Land O..
  - Oman
  - Ostblock
  - Osttimor
- News zum Land P..
  - Pakistan
  - Palästina
  - Panama
  - Papua-Neuguinea
  - Paraguay
  - Peru
  - Philippinen
  - Polen
  - Portugal
- News zum Land R..
  - Ruanda
  - Rumänien
  - Russland
- News zum Land S..
  - Sambia
  - Saudi-Arabien
  - Schweden
  - Schweiz
  - Senegal
  - Serbien
  - Sierra Leone
  - Simbabwe
  - Singapur
  - Slowakei
  - Slowenien
  - Somalia
  - Spanien
  - Sri Lanka
  - Sudan
  - Syrien
  - Südafrika
  - Südkorea
- News zum Land T..
  - Tadschikistan
  - Taiwan (China)
  - Tansania
  - Thailand
  - Togo
  - Tschad
  - Tschechien
  - Tunesien
  - Turkmenistan
  - Türkei
- News zum Land U..
  - Uganda
  - Ukraine
  - Ungarn
  - Uruguay
  - USA
  - Usbekistan
- News zum Land V..
  - Venezuela
  - Vereinigte Arabische Emirate
  - Vietnam
- News zum Land W..
  - Weißrussland
- News zum Land Z..
  - Zentralafrikanische Republik
  - Zypern
- News zum Land Ä..
  - Ägypten
  - Äthiopien
- News zum Land Ö..
  - Österreich

06.07.25 - 02:00	Pro Medicus shares surge 10% to crack $300 as healthcare leads ASX 200 sectors (Fool)
	Pro Medicus shares just keep on going, rising 625% over the past three years. The post Pro Medicus shares surge 10% to crack $300 as healthcare leads ASX 200 sectors appeared first on The Motley Fool Australia....

05.07.25 - 04:36	Why DroneShield, Nickel Industries, and CSL shares could be best buys (Fool)
	Let's see why Bell Potter is so bullish on these shares. The post Why DroneShield, Nickel Industries, and CSL shares could be best buys appeared first on The Motley Fool Australia....

04.07.25 - 02:01	Neurizon significantly advances NUZ-001, enters global licensing agreement (Market Herald)
	Neurizon Therapeutics (ASX:NUZ) has this week arrived at its next “watershed moment”…...

04.07.25 - 00:36	Why this broker just downgraded Pro Medicus shares (Fool)
	Let's see what Bell Potter is saying about this high-flying stock. The post Why this broker just downgraded Pro Medicus shares appeared first on The Motley Fool Australia....

03.07.25 - 13:42	Elanco in licensing pact with Australia’s Neurizon (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

03.07.25 - 10:54	LONDON BROKER RATINGS: Berenberg cuts Rio Tinto; UBS cuts Fresnillo (Alliance)
	The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:----------FTSE 100----------Goldman Sachs raises AstraZeneca price target to 14,806 (14,524) pence - 'buy'----------Jefferies raises......

03.07.25 - 07:24	Here are the latest growth forecasts for the CSL share price (Fool)
	Can this biotech giant deliver healthy returns? The post Here are the latest growth forecasts for the CSL share price appeared first on The Motley Fool Australia....

03.07.25 - 05:42	Australia′s Pro Medicus soars to record high on new contract wins (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

03.07.25 - 04:48	Why Dominos, NRW, Pro Medicus, and WIA Gold shares are charging higher today (Fool)
	These shares are avoiding the market weakness and are pushing higher today. But why? The post Why Domino's, NRW, Pro Medicus, and WIA Gold shares are charging higher today appeared first on The Motley Fool Australia....

03.07.25 - 02:48	UP 127% in a year, why is the Pro Medicus share price rocketing higher again today? (Fool)
	ASX investors are sending Pro Medicus shares flying higher on Thursday. But why? The post UP 127% in a year, why is the Pro Medicus share price rocketing higher again today? appeared first on The Motley Fool Australia....

03.07.25 - 01:36	Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001 (PR Newswire)
	Highlights: Neurizon® Therapeutics and Elanco Animal Health enter into an exclusive global licensing agreement Provides worldwide rights for Neurizon to utilise Elanco's intellectual property, providing exclusive access to an extensive package of non-clinical studies and manufacturing......

02.07.25 - 02:01	Race Oncology accelerates gamechanging cancer drug (Market Herald)
	In this HotCopper Capital Compass interview, Race Oncology (ASX:RAC) chairman Dr Pete…...

01.07.25 - 22:09

Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025 (GlobeNewswire EN)

SAN DIEGO, July 01, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2025 on Thursday, July 31, 2025, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast....

01.07.25 - 16:06	Mesoblast, FDA agree on marketing application for cell therapy (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

01.07.25 - 04:01	Paradigm unlocks $40M loan – and sees a 75cps price not far away (Market Herald)
	Paradigm Biopharmaceuticals (ASX:PAR) shares were up nearly +25% in morning trades as…...

01.07.25 - 02:39

Mesoblast and FDA Align on Key Items for Revascor® Biologic License Application in Ischemic Heart Failure (GlobeNewswire EN)

NEW YORK, June 30, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced alignment with the United States Food and Drug Administration (FDA) on items required for filing a Biologics License Application (BLA) for Revascor® (rexlemestrocel-L) in the treatment of patients with ischemic heart failure with reduced ejection fraction (HFrEF) and inflammation....

30.06.25 - 14:30	Actinogen confirms 100th participant in XanaMIA phase 2b/3 Alzheimer′s disease trial and interim analysis timeline (PR Newswire)
	Interim analysis planned for January 2026 with final trial results in late 2026 Highlights: With the 100th participant enrolled in the XanaMIA trial, the timeline for the planned interim analysis is confirmed for January 2026 and the timeline for final results reconfirmed for late 2026 An......

30.06.25 - 03:48	Now trading at an attractive price, why CSL shares look set for a rebound (Fool)
	These leading fund managers expect CSL shares to put in a much stronger performance in FY 2026. The post Now trading at an 'attractive price', why CSL shares look set for a rebound appeared first on The Motley Fool Australia....

30.06.25 - 02:01	With 100 enrolled and $13.8M in hand, Actinogen’s Xanamem timeline is in full swing (Market Herald)
	Actinogen Medical (ASX:ACW) has this week enrolled its 100th participant for its…...

27.06.25 - 08:01	Monash IVF shares cater 25% – Disaster or deep-value play? (Market Herald)
	Monash IVF Group (ASX:MVF) is back in the headlines, and for all…...

>weitere News anzeigen...